Related Experiment Video
Updated: Aug 16, 2025
Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts
Published on: October 21, 2022
Evaluation of the corneal biomechanical properties and corneal thickness in patients with Graves' orbitopathy
Ferdane Ataş1, Gül Arikan2, Meltem Söylev Bajin2
1Department of Ophthalmology, Çerkezköy State Hospital, Cumhuriyet Mah. Melisa sok, Forest City 1 Sitesi, B1 blok, No: 15, Çerkezköy, Tekirdağ, Turkey. ferdaneatas@gmail.com.
Purpose:
To evaluate the corneal biomechanical properties and central corneal thickness in patients with Graves' orbitopathy (GO).
Method:
A total of 132 eyes of 66 patients with GO and 108 eyes of 54 healthy subjects were enrolled. Eyes with GO were classified as high score clinical activity score (CAS, ≥ 3) (Group 1, n = 64) and low CAS score (< 3) (Group 2, n = 68). Corneal biomechanical parameters [corneal hysteresis (CH), corneal resistance factor (CRF)], Goldmann-correlated intraocular pressure (IOPg), and corneal-compensated IOP (IOPcc) levels were measured with Ocular Response Analyzer (ORA, Reichert Ophthalmic Instruments, Buffalo, NY) and compared between the groups.
Results:
The mean CH values were found as 9.6 ± 1 mmHg in Group 1, 10.2 ± 0.9 mmHg in Group 2, and 11.4 ± 1.7 mmHg in the Control Group (p < 0.001). In post hoc analysis the mean CH was significantly lower in Group 1 than Group 2 and Control Group (Group 1-Group 2, p < 0.001; Group 1-Control Group, p < 0.001). The mean CRF was found as 10.5 ± 2.1 in Group 1, 10.4 ± 2.2 in Group 2, and 10.43 ± 2.0 in the Control group. There was no statistically significant difference between the groups in CRF measurements (p = 0.959). The mean IOPcc values were found as 17.1 ± 3.6 mmHg in Group 1, 15.8 ± 4.0 mmHg in Group 2 and 15.2 ± 4.1 mmHg in the Control Group. The IOPcc and IOPg measurements between all groups were statistically significant (p = 0.009, p = 0.027, respectively).
Conclusions:
Corneal biomechanical measurements were different in the GO patients with varying CAS scores compared to healthy individuals.
